Current perspectives on the development of Industry 4.0 in the pharmaceutical sector

Simple item page
dc.contributor.authorReinhardt, Ingrid Carla
dc.contributor.authorOliveira, Jorge C.
dc.contributor.authorRing, Denis T.
dc.contributor.funderUniversity College Corken
dc.date.accessioned2020-03-10T12:21:24Z
dc.date.available2020-03-10T12:21:24Z
dc.date.issued2020-02-13
dc.date.updated2020-02-25T10:07:19Z
dc.description.abstractIndustry 4.0 is a concept that represents the adoption by industry of techniques and processes allowed by digitisation, cloud computing, the internet of things and big data to gain competitive advantages in domestic and global markets. The research is conducted in Ireland with the resulting data examined through a global lens, yielding information relevant to the effective adoption and integration of 4.0 concepts. Key outcomes are the perspectives of the pharmaceutical and biopharmaceutical industries with regards to the adoption of 4.0, the current level of implementation of 4.0 technologies in manufacturing facilities and planned 4.0 projects to be executed. Statistically relevant relationships evident in the responses are also investigated. This research provides novel and highly relevant information concerning the state of industry preparedness for the adoption of 4.0. Across all survey respondents only 42% indicated any knowledge of 4.0. The majority of respondents who indicated a knowledge of 4.0 identified with either the Automation or Engineering department. Among established employees with greater than 8 years of experience 82% identified with having knowledge of 4.0. Those surveyed with Vice-President or Director roles, had a 98% certainty of 4.0 awareness. A noteworthy finding of this work is the identification of a substantial disconnect in knowledge of 4.0 based on seniority, function and industry. Thus while the implementation of 4.0 is playing an increasingly significant role in the modernisation of the Pharmaceutical and Biopharmaceutical industries, challenges remain with respect to the holistic fusion of 4.0 into the culture of organisations.en
dc.description.sponsorshipUniversity College Cork (College of Science, Engineering and Food Science)en
dc.description.statusPeer revieweden
dc.description.versionAccepted Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.articleid100131en
dc.identifier.citationReinhardt, I. C., Oliveira, J. C. and Ring, D. T. (2020) 'Current perspectives on the development of Industry 4.0 in the pharmaceutical sector', Journal of Industrial Information Integration, 18, 100131 (11pp). doi: 10.1016/j.jii.2020.100131en
dc.identifier.doi10.1016/j.jii.2020.100131en
dc.identifier.endpage11en
dc.identifier.issn2452-414X
dc.identifier.issn2452-414X
dc.identifier.journaltitleJournal of Industrial Information Integrationen
dc.identifier.startpage1en
dc.identifier.urihttps://hdl.handle.net/10468/9741
dc.identifier.volume18en
dc.language.isoenen
dc.publisherElsevier Inc.en
dc.relation.urihttp://www.sciencedirect.com/science/article/pii/S2452414X20300066
dc.rights© 2020, Elsevier B.V. All rights reserved. This manuscript version is made available under the CC BY-NC-ND 4.0 license.en
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subjectIndustry 4.0en
dc.subject4th industrial revolutionen
dc.subjectPharma 4.0en
dc.subjectIrish pharmaceutical sectoren
dc.subjectSurveyen
dc.titleCurrent perspectives on the development of Industry 4.0 in the pharmaceutical sectoren
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
10.1016j.jii.2020.100131.pdf
Size:
1.13 MB
Format:
Adobe Portable Document Format
Description:
Accepted Version
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Process and Chemical Engineering - Journal Articles